Novel therapeutic targets in axial spondyloarthritis
<strong>Purpose of review</strong> Axial spondyloarthritis remains an area of significant unmet clinical need with only two immune pathways currently targeted by licenced therapies compared to other immune-mediated inflammatory joint disorders such as rheumatoid arthritis where a multitu...
| Main Authors: | , , |
|---|---|
| 格式: | Journal article |
| 出版: |
Springer International Publishing
2018
|